Another approach for increasing EAAT2 expression comprises the use of compounds that may increase EAAT2 expression through translational activation, such as a pyridazine derivative LDN/OSU-0212320, which was tested in the SOD1G93A mouse model of ALS [242]. This evidence concerns the gene SLC1A2 and amyotrophic lateral sclerosis.